Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients with Relapsed/Refractory Indolent Lymphoma

Drug Category : Array
Conference Category : Array
Lead Author : Fowler N, et al.
Published Date : 09/03/2021
Download Link : https://ascopubs.org/doi/full/10.1200/JCO.20.03433
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top